Stem cells in urology

被引:28
作者
Aboushwareb, Tamer [1 ]
Atala, Anthony [1 ,2 ]
机构
[1] Wake Forest Univ, Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC 27157 USA
[2] Wake Forest Univ, Sch Med, Dept Urol, Winston Salem, NC 27157 USA
来源
NATURE CLINICAL PRACTICE UROLOGY | 2008年 / 5卷 / 11期
关键词
amniotic-fluid-derived stem cells; human embryonic stem cells; regenerative medicine; stem cells; tissue engineering;
D O I
10.1038/ncpuro1228
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The shortage of donors for organ transplantation has stimulated research on stem cells as a potential resource for cell-based therapy in all human tissues. Stem cells have been used for regenerative medicine applications in many organ systems, including the genitourinary system. The potential applications for stem cell therapy have, however, been restricted by the ethical issues associated with embryonic stem cell research. Instead scientists have explored other cell sources, including progenitor and stem cells derived from adult tissues and stem cells derived from the amniotic fluid and placenta. In addition, novel techniques for generating stem cells in the laboratory are being developed. These techniques include somatic cell nuclear transfer, in which the nucleus of an adult somatic cell is placed into an oocyte, and reprogramming of adult cells to induce stem-cell-like behavior. Such techniques are now being used in tissue engineering applications, and some of the most successful experiments have been in the field of urology. Techniques to regenerate bladder tissue have reached the clinic, and exciting progress is being made in other areas, such as regeneration of the kidney and urethra. Cell therapy as a treatment for incontinence and infertility might soon become a reality. Physicians should be optimistic that regenerative medicine and tissue engineering will one day provide mainstream treatment options for urologic disorders.
引用
收藏
页码:621 / 631
页数:11
相关论文
共 97 条
[1]   Erythropoietin producing cells for potential cell therapy [J].
Aboushwareb, Tamer ;
Egydio, Fernanda ;
Straker, Lauren ;
Gyabaah, Kenneth ;
Atala, Anthony ;
Yoo, James J. .
WORLD JOURNAL OF UROLOGY, 2008, 26 (04) :295-300
[2]  
AEBISCHER P, 1987, LIFE SUPPORT SYST, V5, P159
[3]   Renal therapy using tissue-engineered constructs and gene delivery [J].
Amiel, GE ;
Yoo, JJ ;
Atala, A .
WORLD JOURNAL OF UROLOGY, 2000, 18 (01) :71-79
[4]  
Anker PSI, 2003, HAEMATOLOGICA, V88, P845
[5]   Tissue-engineered autologous bladders for patients needing cystoplasty [J].
Atala, A ;
Bauer, SB ;
Soker, S ;
Yoo, JJ ;
Retik, AB .
LANCET, 2006, 367 (9518) :1241-1246
[6]   Adult bone marrow stem cells for cell and gene therapies: Implications for greater use [J].
Ballas, CB ;
Zielske, SP ;
Gerson, SL .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2002, :20-28
[7]   Novel method for the isolation and characterisation of the putative prostatic stem cell [J].
Bhatt, RI ;
Brown, MD ;
Hart, CA ;
Gilmore, P ;
Ramani, VAC ;
George, NJ ;
Clarke, NW .
CYTOMETRY PART A, 2003, 54A (02) :89-99
[8]   Reprogramming efficiency following somatic cell nuclear transfer is influenced by the differentiation and methylation state of the donor nucleus [J].
Blelloch, Robert ;
Wang, Zhongde ;
Meissner, Alex ;
Pollard, Steven ;
Smith, Austin ;
Jaenisch, Rudolf .
STEM CELLS, 2006, 24 (09) :2007-2013
[9]   GERMLINE TRANSMISSION OF DONOR HAPLOTYPE FOLLOWING SPERMATOGONIAL TRANSPLANTATION [J].
BRINSTER, RL ;
AVARBOCK, MR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (24) :11303-11307
[10]   Producing primate embryonic stem cells by somatic cell nuclear transfer [J].
Byrne, J. A. ;
Pedersen, D. A. ;
Clepper, L. L. ;
Nelson, M. ;
Sanger, W. G. ;
Gokhale, S. ;
Wolf, D. P. ;
Mitalipov, S. M. .
NATURE, 2007, 450 (7169) :497-U3